Artificial Intelligence in Predictive Toxicology
A Global Strategic Business Report
MCP29264
WHAT'S BEHIND OUR DATA?
140857226
DOMAIN TRANSCRIPTS6080276
BRANDS TRACKED1729341
FEATURED COMPANIES22574
TOPICS COVERED82719
MARKET SEGMENTS91
KEY INDUSTRIES1574
CURATION TEAM4761909
DECISION MAKERSEXECUTIVE ENGAGEMENTS BY TIER (55)
3
CXO5
VICE PRESIDENT10
DIRECTOR25
MANAGER12
MARKETING
REQUEST FULL-STACK INDEX
Includes 350+ pages validated sources
QUESTIONNAIRE
EXECUTIVES
DATA ROOM
HIGHLIGHTS & REPORT INDEX
Global Artificial Intelligence in Predictive Toxicology Market to Reach US$2.2 Billion by 2030
The global market for Artificial Intelligence in Predictive Toxicology estimated at US$508.8 Million in the year 2024, is expected to reach US$2.2 Billion by 2030, growing at a CAGR of 27.5% over the analysis period 2024-2030. Solutions Component, one of the segments analyzed in the report, is expected to record a 24.8% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Services Component segment is estimated at 33.2% CAGR over the analysis period.
The U.S. Market is Estimated at US$133.7 Million While China is Forecast to Grow at 26.2% CAGR
The Artificial Intelligence in Predictive Toxicology market in the U.S. is estimated at US$133.7 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$333.3 Million by the year 2030 trailing a CAGR of 26.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 24.7% and 24.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 19.3% CAGR.
Global Artificial Intelligence in Predictive Toxicology Market - Key Trends & Drivers Summarized
How Is AI Revolutionizing Toxicology Testing?
Artificial Intelligence (AI) is transforming toxicology by enabling faster, more accurate, and cost-effective methods for predicting the toxicity of chemicals and substances. Traditional toxicological assessments, which often rely on animal testing and lengthy experimental procedures, are being replaced by AI-powered predictive models that simulate human responses based on large datasets. AI leverages machine learning (ML), deep learning (DL), and data analytics to analyze molecular structures and predict potential toxic effects with high precision.
One of the key applications of AI in predictive toxicology is its ability to identify toxic substances at an early stage of drug development or chemical manufacturing. By analyzing vast datasets from chemical properties, biological interactions, and experimental results, AI systems can quickly identify compounds that are likely to be harmful. This accelerates the development process and significantly reduces the time and cost associated with safety testing. AI’s ability to predict toxicity in various biological systems also reduces the reliance on animal testing, aligning with ethical and regulatory standards.
AI models also enhance the ability to predict the long-term effects of exposure to chemicals, such as carcinogenicity, reproductive toxicity, and neurotoxicity. These capabilities are crucial for industries such as pharmaceuticals, chemicals, and environmental safety, where early identification of harmful substances can save lives and prevent regulatory violations.
What Drives the Adoption of AI in Predictive Toxicology?
The growing emphasis on safety and regulatory compliance is a significant driver of AI adoption in predictive toxicology. With increasing global concerns about environmental pollution, chemical exposure, and the ethical implications of animal testing, AI offers a promising alternative to traditional toxicology practices. AI systems provide regulatory bodies and industries with more reliable, scalable, and accurate methods for assessing chemical safety.
Additionally, the rise of precision medicine and personalized health care is accelerating the need for advanced predictive tools in toxicology. As more individualized drugs are developed, understanding how specific compounds affect different genetic profiles becomes increasingly important. AI’s ability to analyze complex biological data and predict toxicological effects based on an individual’s genetic makeup enhances drug safety and efficacy, ensuring that treatments are tailored to specific patient groups.
The shift toward more efficient and sustainable research practices is also driving the adoption of AI in predictive toxicology. Traditional toxicological studies can be time-consuming and expensive, while AI systems enable high-throughput screening and rapid toxicity predictions. This reduces the overall cost of product development, particularly in the pharmaceutical, chemical, and consumer goods industries, where safety testing is critical to market entry.
Can AI Improve the Accuracy and Efficiency of Toxicity Prediction?
AI is significantly improving the accuracy and efficiency of toxicity prediction, addressing the limitations of conventional methods. Traditional toxicology testing often involves extensive in vivo studies, which can be costly and time-consuming. AI algorithms, by analyzing large datasets of chemical properties and biological outcomes, can predict toxicity with a level of accuracy and speed that is far superior to manual methods. These AI-driven models can rapidly analyze millions of compounds, prioritizing those that need further investigation.
Furthermore, AI systems improve prediction accuracy by accounting for complex variables that influence toxicity, such as metabolic processes and genetic variations. By integrating data from genomics, proteomics, and other disciplines, AI enhances the predictive capabilities of toxicology models, making them more robust and reliable. This enables early-stage detection of potential safety concerns, leading to safer chemicals and drugs entering the market.
Another major advantage of AI in predictive toxicology is its ability to continuously learn from new data. As more toxicological data becomes available, machine learning algorithms refine their predictions, improving over time. This iterative learning process ensures that AI systems remain at the forefront of accuracy, enabling better risk assessments and improving safety profiles for chemicals and pharmaceuticals.
What’s Driving the Growth of the AI in Predictive Toxicology Market?
The growth in the Artificial Intelligence in Predictive Toxicology market is driven by several key factors, reflecting the increasing demand for safer and more efficient testing methods. The rising global demand for pharmaceutical and chemical products, coupled with stringent safety regulations, is fueling the need for advanced predictive toxicology tools. AI offers an efficient, scalable solution to meet these demands, significantly reducing the cost and time required for toxicity testing.
The growing shift toward sustainable and ethical testing methods is also propelling AI adoption. As public and regulatory pressure to reduce animal testing increases, AI-powered models offer a viable alternative for assessing chemical safety without the ethical concerns associated with animal studies.
Technological advancements in AI, such as deep learning, big data analytics, and high-performance computing, are enhancing the predictive capabilities of toxicology models. These innovations are enabling AI systems to process vast amounts of data from various sources, improving the accuracy of toxicity predictions.
Finally, the integration of AI in environmental safety and the growing importance of regulatory compliance are supporting the adoption of AI-driven predictive toxicology tools across multiple industries. These factors, combined with increasing investments in AI research, are fueling the rapid growth of the market and establishing AI as a key player in the future of toxicology testing.
SCOPE OF STUDY
The report analyzes the Artificial Intelligence in Predictive Toxicology market by the following Segments, and Geographic Regions/Countries:
Segments:
Component (Solutions Component, Services Component); Technology (Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology, Other Technologies); Toxicity Endpoint (Genotoxicity Endpoint, Hepatotoxicity Endpoint, Neurotoxicity Endpoint, Cardiotoxicity Endpoint, Other Toxicity Endpoints); End-Use (Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use, Other End-Uses).
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World..
SELECT PLAYERS
AbbVie, Inc.; BenevolentAI; Biovista Inc.; ChemAxon; Enzo Biochem, Inc.; Insilico Medicine; Instem Plc; Lhasa Limited; Recursion Pharmaceuticals; Revvity
AI INTEGRATIONS
We’re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy |
| How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind |
| Economic Frontiers: Trends, Trials & Transformations |
| Artificial Intelligence in Predictive Toxicology – Global Key Competitors Percentage Market Share in 2024 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for 36 Players Worldwide in 2024 (E) |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Preclinical Drug Testing Needs Drive Growth of AI-Driven Toxicity Prediction Models |
| Demand for AI in Reducing Animal Testing Strengthens Case for Ethical Toxicology Solutions |
| AI-Enhanced Toxicology Workflows Drive Market Demand in Drug Safety Assessment |
| Emerging AI Tools for Environmental Toxicology Highlight Market Potential |
| AI Models for Carcinogenicity Prediction Spur Growth in Chemical Risk Assessment |
| Advancements in AI for Neurotoxicity Screening Propel Innovation in CNS Drug Development |
| AI Solutions for Predictive Risk Assessment Sustain Growth in Consumer Product Testing |
| AI in Food Toxicology Highlights Opportunities for Safer Food Additives |
| AI-Driven Endocrine Disruptor Screening Strengthens Case for Safer Product Formulation |
| Integration of AI in Nanotoxicology Sets the Stage for Innovations in Material Safety |
| AI Tools for Dermal Toxicity Testing Propel Growth in Cosmetic Safety Markets |
| Growing Focus on AI in Reproductive Toxicity Studies Bodes Well for Regulatory Adherence |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Artificial Intelligence in Predictive Toxicology Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030 |
| World Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Solutions Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Solutions Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Services Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Services Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Cardiotoxicity Endpoint by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Cardiotoxicity Endpoint by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Other Toxicity Endpoints by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Other Toxicity Endpoints by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Genotoxicity Endpoint by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Genotoxicity Endpoint by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Hepatotoxicity Endpoint by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Hepatotoxicity Endpoint by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Neurotoxicity Endpoint by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Neurotoxicity Endpoint by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Chemical & Cosmetics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Chemical & Cosmetics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Contract Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Contract Research Organizations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Machine Learning Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Machine Learning Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Natural Language Processing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Natural Language Processing Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Computer Vision Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Computer Vision Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World 6-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Artificial Intelligence in Predictive Toxicology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E) |
| USA Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| USA 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| USA 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| USA 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| USA 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Canada 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Canada 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Canada 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Canada 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030 |
| JAPAN |
| Artificial Intelligence in Predictive Toxicology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E) |
| Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Japan 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Japan 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Japan 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Japan 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030 |
| CHINA |
| Artificial Intelligence in Predictive Toxicology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E) |
| China Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| China 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| China 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| China 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| China 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030 |
| EUROPE |
| Artificial Intelligence in Predictive Toxicology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E) |
| Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030 |
| FRANCE |
| Artificial Intelligence in Predictive Toxicology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E) |
| France Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| France 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| France 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| France 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| France 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030 |
| GERMANY |
| Artificial Intelligence in Predictive Toxicology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E) |
| Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Germany 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Germany 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Germany 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Germany 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Italy 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Italy 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Italy 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Italy 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030 |
| UNITED KINGDOM |
| Artificial Intelligence in Predictive Toxicology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E) |
| UK Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| UK 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| UK 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| UK 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| UK 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030 |
| ASIA-PACIFIC |
| Artificial Intelligence in Predictive Toxicology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030 |
| REST OF WORLD |
| Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of World 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030 |
| Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of World 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030 |
| Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of World 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030 |
| Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of World 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030 |
COMPETITIVE METRICS
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]